These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 32533824)
21. Predicting Mortality Due to SARS-CoV-2: A Mechanistic Score Relating Obesity and Diabetes to COVID-19 Outcomes in Mexico. Bello-Chavolla OY; Bahena-López JP; Antonio-Villa NE; Vargas-Vázquez A; González-Díaz A; Márquez-Salinas A; Fermín-Martínez CA; Naveja JJ; Aguilar-Salinas CA J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32474598 [TBL] [Abstract][Full Text] [Related]
22. Pre-existing diabetes is worse for SARS-CoV-2 infection; an endothelial perspective. La Sala L; Luzi L; Pontiroli AE Nutr Metab Cardiovasc Dis; 2020 Sep; 30(10):1855-1856. PubMed ID: 32807635 [No Abstract] [Full Text] [Related]
23. Diabetes mellitus and SARS-CoV-2-related mortality: the impact of acute hyperglycemic crises and some further considerations. Patoulias D; Katsimardou A; Papadopoulos C; Doumas M Acta Diabetol; 2021 Jan; 58(1):125-126. PubMed ID: 32816107 [No Abstract] [Full Text] [Related]
24. Analysis of clinical features and pulmonary CT features of coronavirus disease 2019 (COVID-19) patients with diabetes mellitus. Yan Y; Yang F; Zhu X; Wang M; Sun Z; Zhao T; Yang X; Zou Y Endokrynol Pol; 2020; 71(5):367-375. PubMed ID: 33125688 [TBL] [Abstract][Full Text] [Related]
25. SARS-CoV-2 infection in patients with diabetes mellitus and hypertension: a systematic review. Deravi N; Fathi M; Vakili K; Yaghoobpoor S; Pirzadeh M; Mokhtari M; Fazel T; Ahsan E; Ghaffari S Rev Cardiovasc Med; 2020 Sep; 21(3):385-397. PubMed ID: 33070543 [TBL] [Abstract][Full Text] [Related]
26. Challenges of diabetes management during the COVID-19 pandemic. Scott ES; Jenkins AJ; Fulcher GR Med J Aust; 2020 Jul; 213(2):56-57.e1. PubMed ID: 32583422 [No Abstract] [Full Text] [Related]
28. Type 2 diabetes as a major risk factor for COVID-19 severity: a meta-analysis. Pinto LC; Bertoluci MC Arch Endocrinol Metab; 2020; 64(3):199-200. PubMed ID: 32555985 [No Abstract] [Full Text] [Related]
29. Impact of Diabetes in Patients Diagnosed With COVID-19. Abu-Farha M; Al-Mulla F; Thanaraj TA; Kavalakatt S; Ali H; Abdul Ghani M; Abubaker J Front Immunol; 2020; 11():576818. PubMed ID: 33335527 [TBL] [Abstract][Full Text] [Related]
30. Coronavirus Disease (COVID-19) Caused by (SARS-CoV-2) Infections: A Real Challenge for Human Gut Microbiota. Vodnar DC; Mitrea L; Teleky BE; Szabo K; Călinoiu LF; Nemeş SA; Martău GA Front Cell Infect Microbiol; 2020; 10():575559. PubMed ID: 33363049 [TBL] [Abstract][Full Text] [Related]
31. Response: The Risk of Diabetes on Clinical Outcomes in Patients with Coronavirus Disease 2019: A Retrospective Cohort Study ( Chung SM; Ahn JH; Moon JS Diabetes Metab J; 2020 Aug; 44(4):625-626. PubMed ID: 32856805 [No Abstract] [Full Text] [Related]
32. Letter: The Risk of Diabetes on Clinical Outcomes in Patients with Coronavirus Disease 2019: A Retrospective Cohort Study ( Kim SY; Kim KS Diabetes Metab J; 2020 Aug; 44(4):621-622. PubMed ID: 32856803 [No Abstract] [Full Text] [Related]
33. Age but not sex may explain the negative effect of arterial hypertension and diabetes on COVID-19 prognosis. Pirola CJ; Sookoian S J Infect; 2020 Oct; 81(4):647-679. PubMed ID: 32407757 [No Abstract] [Full Text] [Related]
34. The coronavirus disease 2019 pandemic: telemedicine in elderly patients with type 2 diabetes. Fatyga E; Dzięgielewska-Gęsiak S; Wierzgoń A; Stołtny D; Muc-Wierzgoń M Pol Arch Intern Med; 2020 May; 130(5):452-454. PubMed ID: 32385978 [No Abstract] [Full Text] [Related]
35. Is newly diagnosed diabetes a stronger risk factor than pre-existing diabetes for COVID-19 severity? Sathish T; de Mello GT; Cao Y J Diabetes; 2021 Feb; 13(2):177-178. PubMed ID: 33107708 [No Abstract] [Full Text] [Related]
36. Diabetes and covid-19: a global health challenge. Shenoy A; Ismaily M; Bajaj M BMJ Open Diabetes Res Care; 2020 Apr; 8(1):. PubMed ID: 32345580 [No Abstract] [Full Text] [Related]
37. Expression of SARS-CoV-2 Entry Factors in the Pancreas of Normal Organ Donors and Individuals with COVID-19. Kusmartseva I; Wu W; Syed F; Van Der Heide V; Jorgensen M; Joseph P; Tang X; Candelario-Jalil E; Yang C; Nick H; Harbert JL; Posgai AL; Paulsen JD; Lloyd R; Cechin S; Pugliese A; Campbell-Thompson M; Vander Heide RS; Evans-Molina C; Homann D; Atkinson MA Cell Metab; 2020 Dec; 32(6):1041-1051.e6. PubMed ID: 33207244 [TBL] [Abstract][Full Text] [Related]
39. SARS-CoV-2 perturbs the renin-angiotensin system and energy metabolism. Mori J; Oudit GY; Lopaschuk GD Am J Physiol Endocrinol Metab; 2020 Jul; 319(1):E43-E47. PubMed ID: 32469255 [TBL] [Abstract][Full Text] [Related]
40. The disproportionate excess mortality risk of COVID-19 in younger people with diabetes warrants vaccination prioritisation. McGovern AP; Thomas NJ; Vollmer SJ; Hattersley AT; Mateen BA; Dennis JM Diabetologia; 2021 May; 64(5):1184-1186. PubMed ID: 33594475 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]